Vahalla, NYNCT04323748Now EnrollingIRB Ready

Immune Thrombocytopenic Purpura Clinical Trial in Vahalla, NY

Access cutting-edge immune thrombocytopenic purpura treatment through this phase 1 clinical trial at a research site in Vahalla. Study-provided care at no cost to qualified participants.

Sponsored by New York Medical College

Quick Self-Assessment

See if you qualify for this Vahalla location

Preparing your pre-screening questions…

Expert Care in Vahalla

Access immune thrombocytopenic purpura specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related immune thrombocytopenic purpura treatment provided free

Apply for This Vahalla Location

Check if you qualify for this immune thrombocytopenic purpura clinical trial in Vahalla, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Vahalla

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Vahalla site if eligible
  4. 4Begin participation

About This Immune Thrombocytopenic Purpura Study in Vahalla

The purpose of this study is to determine if a dose dense administration of Rituximab in newly diagnosed acute immune thrombocytopenic purpura (ITP) and determine relapse rate following this treatment. Correlative studies will be performed as outlined in the appendices. Quality of Life will be measured using the KIT as outlined in the protocol.

Sponsor: New York Medical College

Who Can Participate

Inclusion Criteria

Age: Subjects must be ≥ 1 year and ≤ 21 years of age.
Diagnosis: Patients must have newly diagnosed ITP and a platelet count of ≤ 20 x 109 per Liter. Bone marrow aspirate and biopsy should be performed to rule out malignancy in the bone marrow.
High-risk features : In addition, patients must have one of more of the following high-risk criteria:
Age ≥ 10 years
Grade II-IV bleeding at diagnosis
ANA positivity
No history of preceding infection within 2 weeks prior to ITP diagnosis
Performance Status: Patients must have a performance status ≥ 50%. Use Karnofsky for patients \> 16 years of age and Lansky for patients less than or equal to 16 years of age. See Appendix I for performance score.
Prior Therapy
Patients may not have received any treatment for ITP prior to start of therapy.
Patients may not receive systemic steroids ≥ 0.5 mg/kg prednisone (or equivalent) within 2 weeks prior to diagnosis.
Concomitant Medications Restrictions:
Steroids are only warranted as premedication prior to rituximab.
Patients who receive thrombopoetic agonists, eltrombopag or romiplostim will be taken off protocol.
Organ Function Requirements
Adequate Renal Function Defined As: estimated CrCl \> 60 mL/min or \>30% of GFR for age based on the Schwartz formula
Adequate Liver Function Defined As: AST and/or ALT less than 5 times the upper limit of normal, and/or direct bilirubin less than the 2 times of the upper limit of normal

Exclusion Criteria

Patients with a history of Grade III-IV allergic reaction to rituximab
Patients with bone marrow neoplastic infiltration
Patients with a history of hepatitis B infection
Pregnancy and Breast Feeding
Female patients who are pregnant are ineligible (insert the reason: "due to risks of fetal and teratogenic adverse events as seen in animal/human studies" or "since there is yet no available information regarding human fetal or teratogenic toxicities").
Lactating females are not eligible unless they have agreed not to breastfeed their infants.
Female patients of childbearing potential are not eligible unless a negative pregnancy test result has been obtained.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Vahalla?

Yes, this clinical trial (NCT04323748) has an active research site in Vahalla, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Immune Thrombocytopenic Purpura Treatment Options in Vahalla, NY

If you're searching for immune thrombocytopenic purpura treatment options in Vahalla, NY, this clinical trial (NCT04323748) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Vahalla research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced immune thrombocytopenic purpura specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all immune thrombocytopenic purpura clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in Vahalla, NY

See all multiple myeloma clinical trials recruiting in Vahalla — not just this study.

Browse Multiple Myeloma Trials in Vahalla →

Browse More Trials by Condition

Multiple Myeloma TrialsPulmonary Embolism TrialsRheumatoid Arthritis TrialsInterstitial Cystitis TrialsRetinitis Pigmentosa TrialsThrombocytopenia TrialsAll Conditions →

Ready to Join in Vahalla?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Vahalla, NY